Home › SK Biopharmaceuticals Announces A Strategic Alliance For Innovative Drug Development With Chinese Biopharmaceutical Companies
 

Keywords :   


SK Biopharmaceuticals Announces A Strategic Alliance For Innovative Drug Development With Chinese Biopharmaceutical Companies

2013-03-27 14:56:00| drugdiscoveryonline News Articles

The South Korean pharmaceutical company, SK Biopharmaceuticals, announced that they entered into a collaboration agreement with PKU International HealthCare Group, China, and Shanghai Medicilon, China, for its novel new small molecule SKL-PSY that is being developed for the treatment of depression and bipolar disorder

Tags: development companies chinese drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Atlantic Tropical Weather Outlook
28.09Eastern North Pacific Tropical Weather Outlook
28.09Hurricane Isaac Forecast Discussion Number 9
28.09Post-Tropical Cyclone Helene Graphics
28.09Post-Tropical Cyclone Helene Public Advisory Number 19
28.09Tropical Storm Joyce Graphics
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Wind Speed Probabilities Number 9
More »